betibeglogene autotemcel
| Brand name | Zynteglo |
|---|---|
| Active ingredient | betibeglogene autotemcel |
| Strength | 1.7-20 X 10^6CELL/ML |
| Dosage form | For Injection |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | August 2022 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.